MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1513/annalsats.202406-626oc

Медицинская библиотека · Annals of the American Thoracic Society · 2025

Intermittent versus Daily Therapy for Noncavitary Mycobacterium avium Complex Pulmonary Disease: An Open-Label Randomized Trial.

Nakagawa Taku, Fujita Kohei, Miki Mari, Ito Akihiro, Namkoong Ho, Asakura Takanori, Morimoto Kozo, Hasegawa Naoki, Kita Toshiyuki, Watanabe Akira, Tsuyuguchi Kazunari, Kawashima Masahiro, Shiozawa Ayako, Watanabe Satoru, Sato Atsuo, Kato Tatsuo, Kimizuka Yoshifumi, Harada Hiroaki, Fujita Kaori, Saito Akiko M, Hashimoto Hiroya, Inoue Yoshikazu, Ogawa Kenji

СтатьяРандомизированное исследованиеМногоцентровое исследованиеПеревод в очереди

Аннотация

Rationale: Patients with noncavitary nodular bronchiectatic (NB) Mycobacterium avium complex pulmonary disease (MAC-PD) are treated intermittently three times per week, although no randomized controlled trials have been conducted comparing three times weekly with daily therapy.

Objectives

To assess the tolerability, safety, and efficacy of intermittent versus daily treatment in patients with previously untreated noncavitary NB MAC-PD.

Methods

In an open-label study, patients were randomly assigned to the intermittent therapy group receiving clarithromycin 1,000 mg, rifampicin 600 mg, and ethambutol 25 mg/kg (maximum 1,000 mg) three days per week or the daily therapy group receiving clarithromycin 800 mg, rifampicin 450 mg, and ethambutol 15 mg/kg (maximum 750 mg) daily for 1 year. The primary endpoint was the proportion of patients requiring modification of the initial treatment regimen.

Results

Twenty-one Japanese hospitals participated in the study, enrolling 141 patients between May 2019 and December 2021. The full analysis set included 138 participants (intermittent therapy = 70; daily therapy = 68). There were no significant differences between the intermittent and daily therapy groups in terms of the regimen modification rate (20.0% [14 of 70] vs. 33.8% [23 of 68]; adjusted odds ratio, 0.48; 95% confidence interval, 0.22 to 1.05; P = 0.06) or culture conversion (70.3% vs. 80.0%; P = 0.53), time to culture conversion (28.0 vs. 28.5 d; P = 0.89), improvement in chest CT findings (60.9% vs. 71.0%; P = 0.30), or clarithromycin resistance development (1.4% vs. 0%; P = 1.00). Elevated aspartate aminotransferase (16.9% vs. 41.2%; P = 0.003) and alanine aminotransferase (18.3% vs. 44.1%; P = 0.002) were more common in the daily treatment group, whereas elevated bilirubin (11.3% vs. 1.5%; P = 0.04) and dysgeusia (14.1% vs. 1.5%; P = 0.01) were more common in the intermittent treatment group. The daily treatment group exhibited a greater absolute change in the 36-Item Short Form Health Survey physical aspect score (-2.5 points) than the intermittent treatment group (2.1 points) (P = 0.01).

Conclusions

Intermittent treatment was not significantly better tolerated than daily treatment for noncavitary NB MAC-PD. However, further studies with larger numbers of patients are needed. Clinical trial registered with https://jrct.mhlw.go.jp/en-top (jRCTs031190008).

Для цитирования: Nakagawa Taku, Fujita Kohei, Miki Mari, Ito Akihiro, Namkoong Ho, Asakura Takanori, Morimoto Kozo, Hasegawa Naoki, Kita Toshiyuki, Watanabe Akira, Tsuyuguchi Kazunari, Kawashima Masahiro, Shiozawa Ayako, Watanabe Satoru, Sato Atsuo, Kato Tatsuo, Kimizuka Yoshifumi, Harada Hiroaki, Fujita Kaori, Saito Akiko M, Hashimoto Hiroya, Inoue Yoshikazu, Ogawa Kenji. Intermittent versus Daily Therapy for Noncavitary Mycobacterium avium Complex Pulmonary Disease: An Open-Label Randomized Trial.. Annals of the American Thoracic Society. 2025. DOI: 10.1513/annalsats.202406-626oc.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.